Subject
Endocrinology, Diabetes and Metabolism,Endocrinology
Reference9 articles.
1. Dopamine agonists and pituitary tumor shrinkage;Bevan;Endocrine Reviews,1992
2. Long-term treatment with cabergoline, a new long-lasting ergoline derivative, in idiopathic or tumorous hyperprolactinemia and outcome of drug-induced pregnancy;Ciccarelli;Journal of Endocrinological Investigation,1997
3. The effect of quinagolide and cabergoline, two selective dopamine receptor type-2 agonists, in the treatment of prolactinomas;Di Sarno;Clinical Endocrinology,2000
4. A cross-over study with the two novel dopaminergic drugs cabergoline and quinagolide in hyperprolactinaemic patients;Giusti;Journal of Endocrinological Investigation,1994
5. CV205-502, a new dopamine agonist, versus bromocriptine in the treatment of hyperprolactinaemia;Van Der Heijden;European Journal of Obstetrics, Gynecology and Reproductive Biology,1991
Cited by
12 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献